2023-25677. National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, November 29, 2023, 05:30 p.m. to November 30, 2023, 05:30 p.m., National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Room TE406 & 408, Rockville, MD, 20850 which was published in the Federal Register on September 29, 2023, FR Doc 2023–21441, 88 FR 67328.

This meeting notice is being amended to change the meeting format from hybrid (in-person & virtual) to virtual only. In addition, the National Cancer Advisory Board (NCAB) Subcommittee Meeting on November 29, 2023, will now be held from 1:00 p.m. to 2:00 p.m. instead of 5:30 p.m. to 9:00 p.m. The closed session of the NCAB on November 30, 2023, will now be held from 12:00 p.m. to 1:05 p.m. instead of 4:30 p.m. to 5:30 p.m. The open session of the NCAB and NCI Board of Scientific Advisors (BSA) on November 30, 2023, will now be held from 1:15 p.m. to 5:00 p.m. instead of 8:00 a.m. to 4:15 p.m. The NCAB Subcommittee meeting and open session of the NCAB and BSA can be accessed from the NIH VideoCasting at the following link: https://videocast.nih.gov/​. The meeting is partially closed to the public.

Dated: November 15, 2023.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.